Contribution of the diffusion-weighted MRI in the diagnosis and follow-up of encephalopathy caused by maple syrup urine disease in a full-term newborn

Arquivos de Neuro-Psiquiatria

Volumn 67, Issue 3 A, 2009, Pages 719-723

  Ferraz Filho, José Roberto Lopes ^a,b,c   Floriano, Valdeci Hélio ^b,c   Quirici, Marcelo Bianco ^b,c   De Albuquerque, Regina Pires ^a,c   Souza, Antônio Soares ^a,c  

^a FAMERP Medical School   (Brazil)

^b Department of Radiology ^*  (Brazil)

^c FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ISOLEUCINE; LEUCINE; VALINE;

AMINO ACID BLOOD LEVEL; APGAR SCORE; APNEA; ARTICLE; BIRTH WEIGHT; BRADYCARDIA; BRAIN DISEASE; BRAIN STEM; CAPSULA INTERNA; CASE REPORT; CEREBELLUM; CHEMICAL ANALYSIS; CHROMATOGRAPHY; COMA; DIALYSIS; DIET THERAPY; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INFANT; KETOACIDOSIS; LETHARGY; MALE; MAPLE SYRUP URINE DISEASE; NEWBORN; SEIZURE; SUCKING; TERM BIRTH; WHITE MATTER;

EID: 69749122831     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2009000400033     Document Type: Article

References (12)

1. Ha JS, Kim TK, Eun BL, et al. Maple syrup urine encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI. Pediatr Radiol 2004;34:163-166.
2. Sakai M, Inoue Y, Oba H, et al. Age dependence of diffusion-weighted magnetic resonance imaging findings in maple syrup urine disease encephalopathy. J Comput Assist Tomogr 2005;29:524-1427 (Pubitemid 41060289)
3. Cavalleri F, Berardi A, Burlina AB, Ferrari F, Mavilla L. Diffusion-weighted MRI of maple syrup urine disease encephalopathy. Neuroradiology 2002;44:499-502. (Pubitemid 36067842)
4. Parmar H, Sitoh YY, Ho L. Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings. J Comput Asssist Tomogr 2004;28:93-97. (Pubitemid 38057861)
5. Jan W, Zimmerman RA, Wang ZJ, Berry GT, Kaplan PB, Kaye EM. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology 2003;45:393-399. (Pubitemid 36869239)
6. Righini A, Ramenghi LA, Parini R, Triulzi F, Mosca F. Water apparent diffusion coefficient and T2 changes in the acute stage of maple syrup urine disease: evidence of intramyelinic and vasogenic-interstitial edema. J Neuroimaging 2003;13:162-165. (Pubitemid 36384047)
7. Tavares RG, Santos CE, Tasca CI, Wajner M, Souza DO, Dutra-Filho CS. Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. J Neurol Sci 2000;181:44-49.
8. Felber SR, Sperl W, Chemelli A, Murr C, Wendel U. Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy. Ann Neurol 1993;33:396-401. (Pubitemid 23103974)
9. Jouvet P, Rustin P, Taylor DL, et al. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome C release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 2000;11:1919-1932. (Pubitemid 30307922)
10. Riviello JJ Jr, Rezvani I, DiGeorge AM, Foley CM. Cerebral edema causing death in children with maple syrup urine disease. J Pediatr 1991;119:42-45.
11. Sener RN. Maple syrup urine disease: Maple syrup urine disease: diffusion MRI, and proton MR spectroscopy findings. Comput Med Imaging Graph 2007;31:106-110.
12. Morton DH, Strauss KA, Robinson DL, Puffenberger EG, Kelley RI. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Pediatrics 2002;109:999-1008. (Pubitemid 34587423)